Man Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-443,544
| Closed | -$1.35M | – | 2183 |
|
|
2024
Q4 | $1.35M | Buy |
443,544
+143,544
| +48% | +$436K | ﹤0.01% | 1276 |
|
|
2024
Q3 | $1.56M | Buy |
+300,000
| New | +$1.56M | ﹤0.01% | 1259 |
|
|
2023
Q4 | – | Hold |
0
| – | -$286K | – | 2170 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1645 |
|
|
2023
Q2 | – | Hold |
0
| – | -$8.05M | – | 2224 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 626 |
|
|
2021
Q3 | – | Sell |
-16,600
| Closed | -$492K | – | 2011 |
|
|
2021
Q2 | $492K | Buy |
+16,600
| New | +$492K | ﹤0.01% | 1559 |
|
|
2018
Q3 | – | Sell |
-44,500
| Closed | -$1.22M | – | 2232 |
|
|
2018
Q2 | $1.22M | Sell |
44,500
-100
| -0.2% | -$2.75K | 0.01% | 1534 |
|
|
2018
Q1 | $1.37M | Buy |
+44,600
| New | +$1.37M | 0.01% | 1393 |
|